Article Details
Retrieved on: 2024-11-06 23:09:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In August, Roche-Genentech optioned the first neuroscience phenomap for $30 million, part of a fee structure that could exceed $500 million across ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here